PPIL2 and breast carcinoma: Upregulation of PPIL2 was reported to inhibit EMT and tumor invasion by interacting with the classical EMT transcription factor, SNAI1, to enhance its ubiquitin-dependent degradation in breast cancer (Jia et al., 2018).